Document is current

Any future updates will be listed below

743 Resistance to oncolytic vaccinia can be reversed by targeting regulatory T cells with vaccinia-directed delivery of a TGFβ inhibitor

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.743

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark